Equities research analysts at StockNews.com initiated coverage on shares of RiceBran Technologies (NASDAQ:RIBT – Get Rating) in a research note issued on Saturday. The brokerage set a "sell" rating on the stock.

RiceBran Technologies Stock Performance

Shares of RIBT opened at $0.31 on Friday. The company's 50 day moving average price is $0.57 and its 200 day moving average price is $0.48. RiceBran Technologies has a 52 week low of $0.27 and a 52 week high of $1.03. The company has a market capitalization of $16.22 million, a PE ratio of -1.41 and a beta of 0.45. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.06 and a current ratio of 1.29.

RiceBran Technologies (NASDAQ:RIBT – Get Rating) last posted its earnings results on Thursday, April 28th. The company reported ($0.03) EPS for the quarter. The business had revenue of $10.56 million during the quarter. RiceBran Technologies had a negative return on equity of 36.82% and a negative net margin of 33.42%.

Insiders Place Their Bets

Institutional Trading of RiceBran Technologies

Large investors have recently added to or reduced their stakes in the business. Arnhold LLC boosted its holdings in shares of RiceBran Technologies by 23.1% during the 1st quarter. Arnhold LLC now owns 240,000 shares of the company's stock worth $108,000 after buying an additional 45,000 shares during the period. FNY Investment Advisers LLC bought a new stake in shares of RiceBran Technologies during the 2nd quarter worth $71,000. Finally, State Street Corp bought a new stake in shares of RiceBran Technologies during the 1st quarter worth $69,000. 28.60% of the stock is owned by institutional investors.

RiceBran Technologies Company Profile

(Get Rating)

RiceBran Technologies, together with its subsidiaries, operates as a specialty ingredient company. It focuses on producing, processing, and marketing of value-added healthy, natural, and nutrient dense products derived from rice and other small grains. The company converts raw rice bran into stabilized rice bran (SRB) and high value derivative products, including RiBalance, a complete rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious carbohydrate and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich insoluble derivative of RiBalance; and ProRyza products, which includes derivatives composed of protein and protein/fiber blends.

Read More

• Get a free copy of the StockNews.com research report on RiceBran Technologies (RIBT)
• MarketBeat: Week in Review 7/25 – 7/29
• Procter's Earnings Start To Show Weakness In Q4
• The One Question You Have to Ask Before Investing in INTC Stock
• Home Depot: A Beautiful Boring Stock to Navigate a Bear Market
• Could CRISPR Therapeutics be a Moonshot Hiding in Plain Sight?

Receive News & Ratings for RiceBran Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RiceBran Technologies and related companies with MarketBeat.com's FREE daily email newsletter.